A Competing Risk Analysis of Sequential Complication Development in Asian Type 2 Diabetes Mellitus Patients

Overview

Journal Sci Rep

Specialty Science

Date 2015 Oct 29

PMID 26507664

Citations 13

Authors

Li-Jen Cheng

Jeng-Huei Chen

Ming-Yen Lin

Li-Chia Chen

Chun-Huan Lao

Hsing Luh

Shang-Jyh Hwang

Affiliations

Soon will be listed here.

Abstract

This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followed from diagnosis to complications, including myocardial infarction (MI), other ischemic heart disease (IHD), congestive heart failure (CHF), stroke, chronic kidney disease (CKD), retinopathy, amputation, death or to the end of study. Cumulative incidences (CIs) of first and second complications were analyzed in 30 and 4 years using the cumulative incidence competing risk method. IHD (29.8%), CKD (24.5%) and stroke (16.0%) are the most common first complications. The further development of T2D complications depends on a patient's existing complication profiles. Patients who initially developed cardiovascular complications had a higher risk (9.2% to 24.4%) of developing IHD or CKD, respectively. All-cause mortality was the most likely consequence for patients with a prior MI (12.0%), so as stroke in patients with a prior MI (10.8%) or IHD (8.9%). Patients with CKD had higher risk of developing IHD (16.3%), stroke (8.9%) and all-cause mortality (8.7%) than end-stage renal disease (4.0%). Following an amputation, patients had a considerable risk of all-cause mortality (42.1%).

Citing Articles

Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.

Tajik A, Varmaghani M, Ghavami V, Saeedi N, Sharifi F, Khajavi A J Diabetes Metab Disord. 2024; 23(2):1929-1940.

PMID: 39610474 PMC: 11599510. DOI: 10.1007/s40200-024-01444-0.

What is the optimal range of fasting stress hyperglycemia ratio for all-cause mortality in American adults: An observational study.

Li J, Yu C, Hu X Medicine (Baltimore). 2024; 103(43):e40288.

PMID: 39470510 PMC: 11521012. DOI: 10.1097/MD.0000000000040288.

Clustering-based risk stratification of prediabetes populations: Insights from the Taiwan and UK Biobanks.

Onthoni D, Chen Y, Lai Y, Li G, Zhuang Y, Lin H J Diabetes Investig. 2024; 16(1):25-35.

PMID: 39387466 PMC: 11693582. DOI: 10.1111/jdi.14328.

Nomogram for prediction of severe community-acquired pneumonia development in diabetic patients: a multicenter study.

Tan R, Liu B, Zhao C, Yan J, Pan T, Zhou M BMC Pulm Med. 2022; 22(1):403.

PMID: 36344933 PMC: 9640903. DOI: 10.1186/s12890-022-02183-9.

Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis.

Zhang X, Wang Y, Yang Z, Chen X, Zhang J, Wang X Aging (Albany NY). 2022; 14(19):8095-8109.

PMID: 36242604 PMC: 9596198. DOI: 10.18632/aging.204340.

References

Karter A, Ferrara A, Liu J, Moffet H, Ackerson L, Selby J . Ethnic disparities in diabetic complications in an insured population. JAMA. 2002; 287(19):2519-27. DOI: 10.1001/jama.287.19.2519. View

Morrish N, Wang S, Stevens L, Fuller J, Keen H . Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; 44 Suppl 2:S14-21. DOI: 10.1007/pl00002934. View

Shah B, Victor J, Chiu M, Tu J, Anand S, Austin P . Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care. 2013; 36(9):2670-6. PMC: 3747942. DOI: 10.2337/dc12-2105. View

Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A . The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003; 26(2):360-6. DOI: 10.2337/diacare.26.2.360. View

Resnick H, Carter E, Lindsay R, Henly S, Ness F, Welty T . Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care. 2004; 27(6):1286-93. DOI: 10.2337/diacare.27.6.1286. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Vinicor F . The public health burden of diabetes and the reality of limits. Diabetes Care. 1998; 21 Suppl 3:C15-8. DOI: 10.2337/diacare.21.3.c15. View

Clarke P, Gray A, Briggs A, Farmer A, Fenn P, Stevens R . A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004; 47(10):1747-59. DOI: 10.1007/s00125-004-1527-z. View

Fox C, Coady S, Sorlie P, Levy D, Meigs J, DAgostino Sr R . Trends in cardiovascular complications of diabetes. JAMA. 2004; 292(20):2495-9. DOI: 10.1001/jama.292.20.2495. View

10.

Wu A, Kong N, de Leon F, Pan C, Tai T, Yeung V . An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia. 2004; 48(1):17-26. DOI: 10.1007/s00125-004-1599-9. View

11.

Kissela B, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K . Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005; 28(2):355-9. DOI: 10.2337/diacare.28.2.355. View

12.

Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N . Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005; 20(6):1048-56. DOI: 10.1093/ndt/gfh813. View

13.

Lanting L, Joung I, Mackenbach J, Lamberts S, Bootsma A . Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005; 28(9):2280-8. DOI: 10.2337/diacare.28.9.2280. View

14.

Hall Y, Hsu C, Iribarren C, Darbinian J, McCulloch C, Go A . The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005; 68(5):2310-6. DOI: 10.1111/j.1523-1755.2005.00691.x. View

15.

Hambleton I, Jonnalagadda R, Davis C, Fraser H, Chaturvedi N, Hennis A . All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care. 2008; 32(2):306-7. PMC: 2628698. DOI: 10.2337/dc08-1504. View

16.

Chan J, Malik V, Jia W, Kadowaki T, Yajnik C, Yoon K . Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301(20):2129-40. DOI: 10.1001/jama.2009.726. View

17.

Wolbers M, Koller M, Witteman J, Steyerberg E . Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009; 20(4):555-61. DOI: 10.1097/EDE.0b013e3181a39056. View

18.

Li Y, Liao Y, Fan A, Zhang X, Balluz L . Asian American/Pacific Islander paradox in diabetic retinopathy: findings from the Behavioral Risk Factor Surveillance System, 2006-2008. Ethn Dis. 2010; 20(2):111-7. View

19.

Khan N, Wang H, Anand S, Jin Y, Campbell N, Pilote L . Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care. 2010; 34(1):96-101. PMC: 3005449. DOI: 10.2337/dc10-0865. View

20.

Chen T, Chung K, Lin I, Lai M . The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?. Health Serv Res. 2010; 46(1 Pt 1):47-60. PMC: 3034261. DOI: 10.1111/j.1475-6773.2010.01182.x. View